SCHEMBL6473141

SCHEMBL6473141

O=C(O)CCc1ccc(Oc2cc(I)c(O)cc2I)c(I)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 5/20 0.58
PCNA P12004 3/20 0.53
POLB P06746 2/20 0.53
THRA P10827 2/20 0.53
THRB P10828 2/20 0.53
HIF1A Q16665 2/20 0.53
MAPK1 P28482 1/20 0.53
TAAR5 O14804 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
FFAR4 Q5NUL3 4/20 0.42
PPARG P37231 2/20 0.41
NR1I2 O75469 1/20 0.41
AGTR2 P50052 1/20 0.41
MEN1 O00255 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
ABCB11 O95342 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
PGR P06401 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6474464 0.86 GAA (0.51) FFAR1PCNAPOLBTHRATHRB
SCHEMBL4238471 0.84 PCNA (0.65) FFAR1PCNAPOLBTHRATHRB
SCHEMBL6473137 0.81 PPARG (0.63) FFAR1PCNAPOLBTHRATHRB
SCHEMBL30492043 0.80 PCNA (0.66) FFAR1PCNAPOLBTHRATHRB
SCHEMBL3269085 0.80 PCNA (0.66) FFAR1PCNAPOLBTHRATHRB
SCHEMBL1446398 0.78 FFAR1 (0.65) FFAR1PCNAFFAR4
SCHEMBL31501676 0.74 FFAR1 (0.60) FFAR1PCNAPOLBTHRATHRB
SCHEMBL30491877 0.74 FFAR1 (0.60) FFAR1PCNAPOLBTHRATHRB
SCHEMBL28641777 0.74 GAA (0.53) FFAR1PCNAPOLBTHRATHRB
SCHEMBL30491880 0.73 FFAR1 (0.67) FFAR1PCNAPOLBTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005123099-A2 METHODS AND COMPOSITIONS FOR ACCELERATING ALCOHOL METABOLISM ENZYMEDIX, INC. (US) 2005-12-29 WO claimed
US-20050271739-A1 Methods and compositions for accelerating alcohol metabolism ENZYMEDIX 2005-12-08 US claimed
WO-2005123099-A2 METHODS AND COMPOSITIONS FOR ACCELERATING ALCOHOL METABOLISM ENZYMEDIX, INC. (US) 2005-12-29 WO disclosed
US-20050271739-A1 Methods and compositions for accelerating alcohol metabolism ENZYMEDIX 2005-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050271739-A1 Methods and compositions for accelerating alcohol metabolism ADH1A, ADH1C, ADH5 FFAR1 1327/4885PCNA 1377/4885POLB 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.